The Cynosure buy at $5.35 establishes a clear insider floor while the company's operating momentum (revenue +23.7%, net income profitable, 5.2% SSS) is accelerating. Monitor for incremental Cynosure buying via 13D or additional Form 4 filings in coming weeks. The $64.4M stake signals strong alignment — treat the stock as having a fundamental floor near $5.35 absent macro deterioration.
Price Chart
Executive Summary
Two insider buys totaling $64.45M at BRCB: the largest shareholder (Cynosure Group, LLC) acquired 12.04M shares at $5.35 on May 15, two days after strong Q1 earnings (revenue +23.7%, net income swing to $1.8M from -$0.9M YoY), and the CMO bought $20K in the open market on May 20. This cluster represents 20.2% of the $319M market cap, a highly material vote of confidence from the largest director/owner, coming amid reaffirmed full-year guidance and an amendment to a Registration Rights Agreement signed May 15 that gave Cynosure additional demand registration rights.
Key Financial Metrics
Key Facts
- Cynosure Group, LLC (Director/10% Owner) bought 12.04M shares at $5.35 on May 15, totaling $64.43M.
- CMO Jessica Wegener-Beyer bought 3,098 shares at $6.46 on May 20, totaling $20,015.
- Cluster value of $64.45M equals ~20.2% of BRCB's $319M market cap — far above the 2% materiality threshold.
- Q1 earnings filed May 12: revenue $55.5M (+23.7% YoY), net income $1.8M vs -$0.9M loss YoY, Same Store Sales +5.2%.
- Full-year 2026 guidance reaffirmed: revenue $255-257M, Adjusted EBITDA $33.5-34.5M.
- An amendment to the Registration Rights Agreement filed May 20 grants Cynosure investors up to 4 demand registration rights (up from 3 for founder group).
- Several other large insider transactions on May 15 were non-cash (conversions/transfers) — $0 economic value.
Financial Impact
Cynosure, a director/10% owner, deployed $64.43M at $5.35/share to acquire 12.04M shares — approximately 20.2% of market cap. This is one of the largest insider buy clusters relative to market cap on record.
Risk Factors
- Historical patterns at BRCB show poor stock performance following high-score analyst reports, though this is a fundamentally different data point (actual insider cash deployment vs. analyst opinion).
- High insider ownership from a single large investor introduces concentrated-seller risk if Cynosure later decides to monetize via registration rights.
- Retail-eatery sector faces potential macro headwinds from consumer spending shifts.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 1 SEC document filed with EDGAR.
| Document | Accession Number |
|---|---|
| CLUSTER Data (Synthetic) | cluster-BRCB-1779399526720 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 23, 2026 3d ago | Press Release | $9.81 | awaiting T+60 | — | $10.37 (+5.71%) |
Oct 9, 2026 18d ago | SC 13G | $7.25 | awaiting T+60 | — | $10.37 (+43.03%) |
Sep 25, 2026 4w ago | Press Release | $7.19 | awaiting T+60 | — | $10.37 (+44.23%) |
Sep 25, 2026 4w ago | Press Release | $7.19 | awaiting T+60 | — | $10.37 (+44.23%) |
Sep 11, 2026 6w ago | Press Release | $8.48 | awaiting T+60 | — | $10.37 (+22.29%) |
Sep 1, 2026 7w ago | Press Release | $9.54 | awaiting T+60 | — | $10.37 (+8.70%) |
Aug 28, 2026 8w ago | Press Release | $9.13 | awaiting T+60 | — | $10.37 (+13.58%) |
Aug 28, 2026 8w ago | Press Release | $9.13 | awaiting T+60 | — | $10.37 (+13.58%) |
Aug 11, 2026 10w ago | Press Release | $8.23 | awaiting T+60 | — | $10.37 (+26.00%) |
Jul 30, 2026 12w ago | Press Release | $7.97 $9.81 | ▲ +23.09% | ▲ +20.62% | $10.37 (+30.11%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers